26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Objective: We conducted a prospective descriptive longitudinal study in patients undergoing elective spine orthopedic surgery from January to June 2019 in order to evaluate whether ketamine attenuates the negative impact on cardiac output and systolic volume of propofol during the induction of general anesthesia. Results: After ketamine administration, all the patients experienced CO and SV levels above the baseline. However, we observed a drop in the CO and SV after propofol administration the mean values maintained above the baseline values in all the patients.Conclusion: A targeted ketamine…mehr

Produktbeschreibung
Objective: We conducted a prospective descriptive longitudinal study in patients undergoing elective spine orthopedic surgery from January to June 2019 in order to evaluate whether ketamine attenuates the negative impact on cardiac output and systolic volume of propofol during the induction of general anesthesia. Results: After ketamine administration, all the patients experienced CO and SV levels above the baseline. However, we observed a drop in the CO and SV after propofol administration the mean values maintained above the baseline values in all the patients.Conclusion: A targeted ketamine plasma concentration of 0.3µg/ml could be useful to attenuate propofol-induced changes on CO and SV during TIVA.
Autorenporträt
Year of Graduation - 1974Year of specialization in Anesthesiology - 1977Master in Medical Emergencies.Professor of Anesthesiology, University of Medical Sciences of Havana.Head of Anesthesiology Service at the Cira García Central Clinic.Former President of TIVAmérica.